Indian Doctors Stress Child-Proof Packs Need

11 August 1997

Reports of cases of aspirin poisoning in children aged below six inIndian pediatric wards in government hospitals, and ingestion of other adult drugs, have sparked calls for child-proof medicine packaging. Recent cases include consumption of 22-35 tablets of a hormonal preparation by two small children, and doctors say cases of small children eating anticonvulsants and overdosing on iron tablets are not uncommon.

Pediatricians are drawing attention to recent US Food and Drug Administration concerns over the high incidence of children in the USA ingesting iron preparations intended for adults as well as highlighting FDA rules on packaging. They say it is vital for drug companies in India to pack all medicines in child-proof packs with warning labels.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight